• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

OPDP Enforcement Actions Webinar - December 19, 2011

 

The Office of Prescription Drug Promotion (OPDP) of the U.S. Food and Drug Administration (FDA), is pleased to inform you of a unique opportunity to participate in the third of our Enforcement Webinars, which will be held on December 19, 2011, from 2:30 p.m. to 3:00 p.m (ET). Viewers can begin submitting questions 30 minutes prior to webinar start time. This is a pilot program in which OPDP will give our stakeholders a chance to directly communicate with the Agency on clarifications or questions about the Warning Letters and Untitled Letters issued by OPDP in a given quarter. This particular webinar will cover Warning Letters and Untitled Letters issued from September 2011 to December 2011.
 
These focused webinars will support OPDP's mission to protect the public health by assuring prescription drug information is truthful, balanced, and accurately communicated.
 
FOR WEB:
To join the meeting:
https://collaboration.fda.gov/ddmac3
 
FOR AUDIO:
Conference Number(s): 301-796-2700
Participant Code: 252580

 
If you have never attended a Connect Pro meeting before:
Test your connection: https://collaboration.fda.gov/common/help/en/support/meeting_test.htm
Get a quick overview: http://www.adobe.com/go/connectpro_overview 
 
Adobe, the Adobe logo, Acrobat and Acrobat Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.